• 1
    Republic of China, National Health Administration. Health Statistics, 1974–80. Taipei: National Health Administration, 44: 19751981.
  • 2
    Beasley RP, Huang LY. Epidemiology of hepatocellular carcinoma. In: VyasGN, DienstagJL, HoofnagleJH, eds. Viral Hepatitis and Liver Disease. Duluth, MN: Grune & Stratton, 1984; 209224.
  • 3
    Lin TM, Tsu WT, Chen CJ. Mortality of hepatoma and cirrhosis of liver. Br J Cancer 1986; 54: 969976.
  • 4
    Steiner PE. Cancer of the liver and cirrhosis in trans-Saharan Africa and the United States of America. Cancer 1960; 13: 10851145.
  • 5
    Szmuness W. Hepatocellular carcinoma and hepatitis B virus: Evidence for causal association. Prog Virol 1978; 24: 4069.
  • 6
    Nishioka K, Hirayama T, Sekine T et al. Australia antigen and hepatocellular carcinoma. Cancer Res 1973; 14: 167175.
  • 7
    Beasley RT, Huang LY, Lin CC et al. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22707 men in Taiwan. Lancet 1981; 2: 11291132.
  • 8
    Summer J, Oconnell A, Maupas P. Hepatitis B virus DNA in primary hepatocellular carcinoma tissue. J Med Virol 1978; 2: 207214.
  • 9
    Shank RC, Bhamarapravati N, Gordon JE, Wogan GN. Dietary aflatoxins in human liver cancer: IV. Incidence of primary cancer in two municipal populations of Thailand. Food and Cosmetics Toxicology 1972; 10: 171179.
  • 10
    Keen PG, Mortin P. Is aflatoxin carcinogenic in man? The evidence in Swaziland. Trop Geogr Med 1971; 23: 4453.
  • 11
    Falk H. Liver. In: SchottenfeldD, FraumeniJJr, eds. Cancer Epidemiology and Prevention. Philadelphia: WB Saunders, 1982; 668682.
  • 12
    Yu MC, Mack T, Hanisch R et al. Hepatitis, alcohol consumption, cigarette smoking and hepatocellular carcinoma in Los Angeles. Cancer Res 1983; 43: 60776097.
  • 13
    St Omer FB, Giannini A, Napoli P. Hepatocellular carcinoma and cirrhosis: A review of their relative incidence in a 25 year period in the Florence area. Hepatogastroenterology 1984; 31: 215217.
  • 14
    Kaw MC, Popper H. Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 1984; 4: 136144.
  • 15
    Christopherson WM, Mays ET, Barrow GH. Liver tumor in women taking oral contraceptives. Obstet Gynecol 1975; 46: 221223.
  • 16
    Baun JK, Holtz F, Bookstein JJ et al. Possible association between benign hepatoma and contraceptives. Lancet 1973; 2: 926929.
  • 17
    Larouze B, London WT, Salmot G et al. Host response to hepatitis B infection in patients with primary hepatic carcinoma and their families: A case/control study in Senegal, West Africa. Lancet 1976; 2: 534538.
  • 18
    Chang MH, Hsu HC, Lee CY et al. Fraternal hepatocellular carcinoma: A case-control study in southern African Blacks. Cancer 1984; 53: 18071810.
  • 19
    Tamburro CH. Relationship of vinyl monomers and liver cancer: Angiosarcoma and hepatocellular carcinoma. Semin Liver Dis 1984; 4: 158169.
  • 20
    Nakashima T, Okuda K, Masamichi K et al. Primary liver cancer coincident with schistosomiasis japonica. Cancer 1975; 36: 483489.
  • 21
    Tricopoulos D, MacMahon B, Sparros L et al. Smoking and hepatitis B negative primary hepatocellular carcinoma. J Nad Cancer Inst 1980; 65: 111114.
  • 22
    Liaw YF, Chu CM, Lin DY et al. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: A comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. J Med Virol 1984; 13: 385391.
  • 23
    Chen CS, Ko YC. Epidemiological aspects of hepatitis B viral infection in preschool children and their parents in a community of southern Taiwan. Kaosiung J Med Sci 1985; 1: 240251.
  • 24
    Chung WK, Sun HS, Park DH et al. Primary hepatocellular carcinoma and hepatitis B virus infection in Korea. J Med Virol 1983; 2: 99104.
  • 25
    Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105: 9498.
  • 26
    Okuda K, Kamiyama I, Inomata M et al. e- antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B to their infants. N Engl J Med 1976; 294: 746749.
  • 27
    Grady GF, Lee VA, Prince AM et al. Hepatitis B immune globulin for accidental exposures among medical personnel: Final report of a multicenter controlled trial. J Infect Dis 1978; 138: 625638.
  • 28
    Seeff LB, Wright EC, Zimmerman HJ. Type B hepatitis after needle stick exposure: Prevention with hepatitis B immune globulin. Ann Intern Med 1978; 88: 285293.
  • 29
    Hofnagle JH, Dusheiko GM, Seeff LB et al. Seroconversion from hepatitis. Ann Intern Med 1981; 94: 744748.
  • 30
    Tiollais P, Charnay P, Vyas GN. Biology of hepatitis B virus. Science 1981; 213: 406411.